Acute pancreatitis: An unexpected toxicity when combining nivolumab and stereotactic body radiation therapy

Pract Radiat Oncol. 2018 Jul-Aug;8(4):e234-e238. doi: 10.1016/j.prro.2017.11.013. Epub 2017 Dec 13.

Authors

Neha P Amin¹, Manuj Agarwal², Maliha Zainib³, Charles B Simone 2nd²

Affiliations

¹ Department of Radiation Oncology, University of Maryland, Baltimore, Maryland. Electronic address: npamin@gmail.com.
² Department of Radiation Oncology, University of Maryland, Baltimore, Maryland.
³ School of Medicine, University of Maryland, Baltimore, Maryland.

PMID: 29452870
DOI: 10.1016/j.prro.2017.11.013

No abstract available

Publication types

Case Reports

MeSH terms

Acute Disease
Aged
Antibodies, Monoclonal / adverse effects*
Antibodies, Monoclonal / pharmacology
Antibodies, Monoclonal / therapeutic use
Combined Modality Therapy / adverse effects*
Combined Modality Therapy / methods
Humans
Male
Nivolumab
Pancreatitis / drug therapy*
Pancreatitis / pathology
Pancreatitis / radiotherapy*
Radiosurgery / adverse effects*
Radiosurgery / methods

Substances

Antibodies, Monoclonal
Nivolumab